Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Homozygous Familial Hypercholesterolemia (HoFH) clinical trials
1 of 2 indexed Homozygous Familial Hypercholesterolemia (HoFH) trials are currently recruiting.
Corpus placement: #7,188 of 28,707 conditions by registered trial count.
2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count
Homozygous Familial Hypercholesterolemia (HoFH): 2 US clinical trials tracked, 1 recruiting.
Homozygous Familial Hypercholesterolemia (HoFH) is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is REGENXBIO, running 1 of these trials.
Enrollment posture brief
Registry condition homozygous-familial-hypercholesterolemia-hofh
OPEN 1 | RECR 50% | LATE 0 | EARLY 0 | RANK #7188 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)
Homozygous Familial Hypercholesterolemia (HoFH) lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Homozygous Familial Hypercholesterolemia (HoFH) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Homozygous Familial Hypercholesterolemia (HoFH) is recruiting above its size-band peers.
1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
2 total, page 1 of 1
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Homozygous Familial Hypercholesterolemia (HoFH) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Homozygous Familial Hypercholesterolemia (HoFH) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Homozygous Familial Hypercholesterolemia (HoFH) page
2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Homozygous Familial Hypercholesterolemia (HoFH) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- REGENXBIO sponsors the most Homozygous Familial Hypercholesterolemia (HoFH) trials on record, review their full trial history before evaluating a specific study. See REGENXBIO's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Homozygous Familial Hypercholesterolemia (HoFH) condition card totals 2 registered trials; most-linked intervention Screening for FH; top US site state Wisconsin. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.